Nobis Nobis Cartel windows 7 home premium activation key
Archivo del sitio

Pemphigus in China

By Dr. Pan Meng Pemphigus is a group of organ-specific autoimmune disorders, including pemphigus vulgaris (PV), pemphigus foliaceus (PF) and paraneoplastic pemphigus (PNP). PV is the most common disease and represents this kind of potentially life-threatening disease. It is characterized

Etiquetado con: , , , , , ,
Publicado en: Médicos

Companion Animals, Too, Can Get Pemphigus

by Thierry Olivry, DrVet, PhD, DipACVD, DipECVD, Associate Professor of Dermatology, Department of Clinical Sciences, College of Veterinary Medicine, NC State University, Raleigh, North Carolina, and Adjunct Clinical Associate Professor of Dermatology, Department of Dermatology, School of Medicine, University of

Etiquetado con: , , , , , , , ,
Publicado en: Médicos

Diagnostic Patterns and Delays in PV: Experience With 99 Pacientes

By David A. Sirois, D.M.D., Ph.D.Department of Oral Medicine Pemphigus vulgaris is a chronic autoimmune disease affecting the mucosa and skin and resulting in epithelial acantholysis, bullae formation, and chronic ulceration.1 Skin lesions of pemphigus vulgaris present clinically with typical

Etiquetado con: , , , ,
Publicado en: Médicos

Development of Non-hormonal Treatment of Pemphigus

By Sergei A. Grando, MD, PhD, DSci Professor of Dermatology University of California Davis The Need for Alternative Therapies for Pemphigus. In autoimmune pemphigus, systemic glucocorticosteroid treatment is life saving but may cause severe side effects. Pemphigus patients therefore need

Etiquetado con: , , , , , , , ,
Publicado en: Médicos

New Perspectives on the Cause of Blister Formation

By Sergei A. Grando, M.D., Ph.D., D.Sci. Professor of Dermatology University of California Davis NPF Advisory Board Member The goal of my research is to develop a safer and more rational treatment for pemphigus. I am deeply concerned that we,

Etiquetado con: , , , , , , ,
Publicado en: Médicos

When the Eyes Have It

By Edward Tenner M.D.Hoffman Estates, Il. Each type of pemphigus and relate diseases has differing kinds and differing percentages of ocular involvement. Also, the treatments for these diseases have many ocular side effects. Therefore it is very important that an

Etiquetado con: , , , , , , ,
Publicado en: Médicos

Cellcept: A Promising New Immunosuppressive Drug

By Grant J. Anhalt, M.D. and Hossein Nousari, M.D.Johns Hopkins University, School of Medicine In February 1997, the FDA approved a new drug, mycophenolate mofetil (MFM, also known as Cellcept) with an approved indication for use in immunosuppression of patients

Etiquetado con: , , , , , , ,
Publicado en: Médicos

Bullous Disease Treatment

Grant J. Anhalt, MD Head, Dermatoimmunology Department Johns Hopkins University Baltimore, Maryland Vice President in charge of Scientific Affairs, The International Pemphigus Foundation

Prior to the introduction of an effective therapy with oral corticosteroids in the 1950s, the disease had a dismal natural course with a 50% mortality rate at 2 years and 100%

Etiquetado con: , , , , , , , ,
Publicado en: Médicos

UNIRSE HOY!

El registro de p y p ha sido aprobado por la Junta de revisión institucional de occidental (WIRB) y activamente es inscribir participantes.

VERSIÓN EN INGLÉS